• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by Oracle Corporation

    1/30/25 5:23:38 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email
    FWP 1 d901407dfwp.htm FWP FWP

    Filed Pursuant to Rule 433

    Registration No. 333-277990

    Issuer Free Writing Prospectus dated January 30, 2025

    Relating to Preliminary Prospectus Supplement dated January 30, 2025 (the “Preliminary Prospectus Supplement”)

    to Prospectus dated March 15, 2024

    ORACLE CORPORATION

    FINAL PRICING TERM SHEET

     

       Floating Rate Notes due 2028 (“2028 Floating Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $500,000,000
    Maturity:    August 3, 2028
    Coupon:    Compounded SOFR, plus 0.760% per year
    Price to Public:    100.000% of the principal amount
    Interest Payment Dates:    February 3, May 3, August 3 and November 3, commencing May 3, 2025
    Day Count Convention:    Actual/360
    Optional Redemption:    Oracle Corporation may not redeem the 2028 Floating Rate Notes prior to maturity
    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XCX1 / US68389XCX12
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)
    Joint Book-Running Managers:   

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

    J.P. Morgan Securities LLC

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    TD Securities (USA) LLC

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank


       4.800% Notes due 2028 (“2028 Fixed Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $1,500,000,000
    Maturity:    August 3, 2028
    Coupon:    4.800%
    Price to Public:    99.930% of the principal amount
    Interest Payment Dates:    February 3 and August 3, commencing August 3, 2025
    Day Count Convention:    30/360
    Benchmark Treasury:    4.250% due January 15, 2028
    Benchmark Treasury Yield:    4.252%
    Spread to Benchmark Treasury:    +57 basis points
    Yield to Maturity:    4.822%
    Optional Redemption:   

    Prior to July 3, 2028 (one month prior to the maturity date (the “2028 Par Call Date”)), Oracle Corporation may redeem the 2028 Fixed Rate Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the 2028 Fixed Rate Notes matured on the 2028 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Preliminary Prospectus Supplement) plus 10 basis points, less (b) interest accrued to the date of redemption, and

     

    (2)   100% of the principal amount of the 2028 Fixed Rate Notes to be redeemed,

     

    plus, in either case, accrued and unpaid interest thereon to the redemption date.

     

    On or after the 2028 Par Call Date, Oracle Corporation may redeem the 2028 Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2028 Fixed Rate Notes being redeemed, plus accrued and unpaid interest thereon to the date of redemption.

    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XCY9 / US68389XCY94
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)


    Joint Book-Running Managers:

      

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

    J.P. Morgan Securities LLC

      

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    TD Securities (USA) LLC

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank


       5.250% Notes due 2032 (“2032 Fixed Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $1,250,000,000
    Maturity:    February 3, 2032
    Coupon:    5.250%
    Price to Public:    99.722% of the principal amount
    Interest Payment Dates:    February 3 and August 3, commencing August 3, 2025
    Day Count Convention:    30/360
    Benchmark Treasury:    4.500% due December 31, 2031
    Benchmark Treasury Yield:    4.428%
    Spread to Benchmark Treasury:    +87 basis points
    Yield to Maturity:    5.298%
    Optional Redemption:   

    Prior to December 3, 2031 (two months prior to the maturity date (the “2032 Par Call Date”)), Oracle Corporation may redeem the 2032 Fixed Rate Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the 2032 Fixed Rate Notes matured on the 2032 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Preliminary Prospectus Supplement) plus 15 basis points, less (b) interest accrued to the date of redemption, and

     

    (2)   100% of the principal amount of the 2032 Fixed Rate Notes to be redeemed,

     

    plus, in either case, accrued and unpaid interest thereon to the redemption date.

     

    On or after the 2032 Par Call Date, Oracle Corporation may redeem the 2032 Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2032 Fixed Rate Notes being redeemed, plus accrued and unpaid interest thereon to the date of redemption.

    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XCZ6 / US68389XCZ69
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)


    Joint Book-Running Managers:   

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

       J.P. Morgan Securities LLC
      

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    TD Securities (USA) LLC

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank

     


       5.500% Notes due 2035 (“2035 Fixed Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $1,750,000,000
    Maturity:    August 3, 2035
    Coupon:    5.500%
    Price to Public:    99.984% of the principal amount
    Interest Payment Dates:    February 3 and August 3, commencing August 3, 2025
    Day Count Convention:    30/360
    Benchmark Treasury:    4.250% due November 15, 2034
    Benchmark Treasury Yield:    4.532%
    Spread to Benchmark Treasury:    +97 basis points
    Yield to Maturity:    5.502%
    Optional Redemption:   

    Prior to May 3, 2035 (three months prior to the maturity date (the “2035 Par Call Date”)), Oracle Corporation may redeem the 2035 Fixed Rate Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the 2035 Fixed Rate Notes matured on the 2035 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Preliminary Prospectus Supplement) plus 15 basis points, less (b) interest accrued to the date of redemption, and

     

    (2)   100% of the principal amount of the 2035 Fixed Rate Notes to be redeemed,

     

    plus, in either case, accrued and unpaid interest thereon to the redemption date.

     

    On or after the 2035 Par Call Date, Oracle Corporation may redeem the 2035 Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2035 Fixed Rate Notes being redeemed, plus accrued and unpaid interest thereon to the date of redemption.

    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XDA0 / US68389XDA00
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)


    Joint Book-Running Managers:

      

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

    J.P. Morgan Securities LLC

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    TD Securities (USA) LLC

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank


       6.000% Notes due 2055 (“2055 Fixed Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $1,750,000,000
    Maturity:    August 3, 2055
    Coupon:    6.000%
    Price to Public:    99.805% of the principal amount
    Interest Payment Dates:    February 3 and August 3, commencing August 3, 2025
    Day Count Convention:    30/360
    Benchmark Treasury:    4.250% due August 15, 2054
    Benchmark Treasury Yield:    4.794%
    Spread to Benchmark Treasury:    +122 basis points
    Yield to Maturity:    6.014%
    Optional Redemption:   

    Prior to February 3, 2055 (six months prior to the maturity date (the “2055 Par Call Date”)), Oracle Corporation may redeem the 2055 Fixed Rate Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the 2055 Fixed Rate Notes matured on the 2055 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Preliminary Prospectus Supplement) plus 20 basis points, less (b) interest accrued to the date of redemption, and

     

    (2)   100% of the principal amount of the 2055 Fixed Rate Notes to be redeemed,

     

    plus, in either case, accrued and unpaid interest thereon to the redemption date.

     

    On or after the 2055 Par Call Date, Oracle Corporation may redeem the 2055 Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2055 Fixed Rate Notes being redeemed, plus accrued and unpaid interest thereon to the date of redemption.

    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XDB8 / US68389XDB82
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)


    Joint Book-Running Managers:   

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

    J.P. Morgan Securities LLC

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    TD Securities (USA) LLC

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank


       6.125% Notes due 2065 (“2065 Fixed Rate Notes”)
    Issuer:    Oracle Corporation
    Principal Amount:    $1,000,000,000
    Maturity:    August 3, 2065
    Coupon:    6.125%
    Price to Public:    99.717% of the principal amount
    Interest Payment Dates:    February 3 and August 3, commencing August 3, 2025
    Day Count Convention:    30/360
    Benchmark Treasury:    4.250% due August 15, 2054
    Benchmark Treasury Yield:    4.794%
    Spread to Benchmark Treasury:    +135 basis points
    Yield to Maturity:    6.144%
    Optional Redemption:   

    Prior to February 3, 2065 (six months prior to the maturity date (the “2065 Par Call Date”)), Oracle Corporation may redeem the 2065 Fixed Rate Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the 2065 Fixed Rate Notes matured on the 2065 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Preliminary Prospectus Supplement) plus 25 basis points, less (b) interest accrued to the date of redemption, and

     

    (2)   100% of the principal amount of the 2065 Fixed Rate Notes to be redeemed,

     

    plus, in either case, accrued and unpaid interest thereon to the redemption date.

     

    On or after the 2065 Par Call Date, Oracle Corporation may redeem the 2065 Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2065 Fixed Rate Notes being redeemed, plus accrued and unpaid interest thereon to the date of redemption.

    Trade Date:    January 30, 2025
    Settlement Date:    February 3, 2025 (T+2)
    CUSIP / ISIN Numbers:    68389XDC6 / US68389XDC65
    Denominations:    $2,000 and multiples of $1,000 thereafter
    Expected Ratings (Moody’s / S&P / Fitch):*    Baa2 (stable) / BBB (stable) / BBB (stable)


    Joint Book-Running Managers:   

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    HSBC Securities (USA) Inc.

    J.P. Morgan Securities LLC

    BNP Paribas Securities Corp.

    Deutsche Bank Securities Inc.

    PNC Capital Markets LLC

    SMBC Nikko Securities America, Inc.

    Co-Managers:   

    NatWest Markets Securities Inc.

    Santander Investment Securities Inc.

    TD Securities (USA) LLC

    BNY Mellon Capital Markets, LLC

    Credit Agricole Securities (USA) Inc.

    ING Financial Markets LLC

    Standard Chartered Bank

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

    The Issuer has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and prospectus supplement if you request it by contacting BofA Securities, Inc., Telephone: 1-800-294-1322; Citigroup Global Markets Inc., Telephone: 1-800-831-9146; Goldman Sachs & Co. LLC, Telephone: 1-866-471-2526; HSBC Securities (USA) Inc., Telephone: 1-866-811-8049; J.P. Morgan Securities LLC, Telephone: 1-212-834-4533, or by emailing Oracle Corporation’s Investor Relations at [email protected].

    Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

    Get the next $ORCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    2/9/2026Buy → Hold
    Melius
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    1/12/2026$240.00Buy
    Goldman
    12/11/2025$355.00 → $270.00Outperform
    BMO Capital Markets
    12/3/2025$280.00Overweight
    Wells Fargo
    11/10/2025Buy → Hold
    Erste Group
    10/13/2025$345.00 → $355.00Outperform
    BMO Capital Markets
    More analyst ratings

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

    AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentation time, freeing time for more meaningful patient interaction LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new AI solution allows caregivers at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, includin

    2/12/26 4:15:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations

    Will unify health record systems with Oracle Health Foundation EHR, implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange across its network AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- Hillsboro Health, an independent, 25-bed critical access hospital based in Hillsboro, Illinois, has chosen Oracle Health solutions to help accelerate innovation, drive operational efficiencies, and enhance patient care. In addition to transitioning from legacy systems to an integrated Oracle Health Foundation EHR, Hillsboro Health plans to leverage Oracle Health Clinical AI Agent, an AI-powered, voice-driven solution, to automate clinical documentation and enable providers to dedicate

    2/11/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid's Modernization Initiative

    OCI to bolster federal health agency's mission critical systems AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has selected Oracle Cloud Infrastructure (OCI) to consolidate and migrate select on-premises workloads to the cloud. OCI will support CMS' modernization efforts by providing secure, scalable cloud infrastructure for the agency's mission-critical systems. By migrating to OCI, CMS will leverage Oracle's FedRAMP® High-authorized infrastructure to meet the most stringent federal security and compliance requirements, along w

    2/11/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously

    2/4/26 7:57:19 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    SEC Filings

    View All

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form CERT filed by Oracle Corporation

    CERT - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:24:57 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-A12B filed by Oracle Corporation

    8-A12B - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:18:28 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:01:31 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Magouyrk Clayton M. sold $1,552,318 worth of shares (10,000 units at $155.23), decreasing direct ownership by 7% to 134,030 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/11/26 4:42:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by EVP, Chief Legal Officer Levey Stuart

    4 - ORACLE CORP (0001341439) (Issuer)

    1/26/26 5:15:41 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    EVP, Principal Financial Offcr Kehring Douglas A sold $6,821,150 worth of shares (35,000 units at $194.89), decreasing direct ownership by 51% to 33,638 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    1/16/26 4:15:34 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SoftBank Group to Acquire Ampere Computing

    SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

    3/19/25 7:30:00 PM ET
    $CG
    $ORCL
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Second Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on December 10, 2025, After the Close of the Market AUSTIN, Texas, Dec. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its second quarter fiscal year 2026 results will be released on Wednesday, December 10th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor.  About Oracle Oracle offers integrated suites of applications plus secure, a

    12/2/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation Announces Promotion of Clay Magouyrk and Mike Sicilia to CEOs; Safra Catz Appointed Executive Vice Chair of the Board of Directors

    AUSTIN, Texas, Sept. 22, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the promotion of Clay Magouyrk and Mike Sicilia to the roles of Chief Executive Officers.  Clay Magouyrk, previously President, Oracle Cloud Infrastructure (OCI), joined Oracle in 2014 from Amazon Web Services. As a founding member of Oracle's cloud engineering team, Clay has overseen the design, implementation and business success of Gen2 of OCI. Oracle Cloud Infrastructure Gen2 is a high-performance, secure, cost-efficient platform that powers both hyperscale public cloud datacenters

    9/22/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology